checkAd

     146  0 Kommentare Radiopharmaceuticals Market Size is Expected to Reach USD 9.934 Billion by 2026 - Valuates Reports - Seite 2

    ●  During the forecast period, the Asia-Pacific radiopharmaceutical market is expected to expand at the fastest pace due to increased patient awareness of cardiovascular diseases and oncology.

    ●  The oncology segment has contributed more than half of the market share in the overall market for radiopharmaceuticals. It is projected to maintain the same trend during the forecast period due to a constant rise in the number of cancer cases.

    Ask for Regional Data: https://reports.valuates.com/request/regional/QYRE-Othe-1Y270/radiopha ...

     

    RADIOPHARMACEUTICALS MARKET SEGMENT BY TYPE

    • Diagnostic Radioisotopes
    • Therapeutic Radioisotopes.

    RADIOPHARMACEUTICALS MARKET SEGMENT BY APPLICATION

    • Oncology
    • Cardiology
    • Other.

    THE MAJOR PLAYERS IN THE GLOBAL RADIOPHARMACEUTICALS MARKET INCLUDE:

    • Bracco Imaging
    • Bayer
    • Mallinckrodt
    • Nordion
    • Triad Isotopes
    • Lantheus
    • IBA Group
    • GE Healthcare
    • China Isotope & Radiation
    • Jubilant Pharma
    • Eli Lilly
    • Advanced Accelerator Applications
    • SIEMENS
    • Dongcheng
    • Navidea
    • Others

    BUY NOW: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Othe-1Y270

    SIMILAR REPORTS :

    ●  Nuclear Medicine Equipment Market Report

    It is estimated that the global nuclear medicine equipment market size will hit USD 2.647 billion by 2022 from USD 2.012 billion in 2015, rising from 2016 to 2022 at a CAGR of 3.9%. The nuclear medicine equipment market size is driven by the availability of high-quality equipment, expanded use of nuclear medicine equipment, and the introduction of new and advanced equipment.

    Nuclear medicine equipment uses radioactive chemicals, which are either intravenously or orally inserted into the body in limited quantities, to diagnose and treat various diseases. By collecting the radiation from these nuclear drugs, nuclear medicine equipment produces images. This method is used to diagnose a disease at an early age, as it monitors molecular processes within the body. It is also used to look at the immediate reactions to therapeutic treatments.

    Seite 2 von 4



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Radiopharmaceuticals Market Size is Expected to Reach USD 9.934 Billion by 2026 - Valuates Reports - Seite 2 BANGALORE, India, April 13, 2020 /PRNewswire/ - The global nuclear medicine/radiopharmaceuticals market size is estimated at USD 5.762 billion in 2020  USD and projected to reach 9.934 billion by the end of 2026, rising at a CAGR of 8.0% in …